These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25992646)

  • 1. Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo.
    Zhang L; Ji YX; Jiang WL; Lv CJ
    Braz J Med Biol Res; 2015 Jun; 48(6):545-52. PubMed ID: 25992646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocatechuic aldehyde ameliorates experimental pulmonary fibrosis by modulating HMGB1/RAGE pathway.
    Zhang L; Ji Y; Kang Z; Lv C; Jiang W
    Toxicol Appl Pharmacol; 2015 Feb; 283(1):50-6. PubMed ID: 25582705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
    Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
    Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ponatinib ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway.
    Qu Y; Zhang L; Kang Z; Jiang W; Lv C
    Pulm Pharmacol Ther; 2015 Oct; 34():1-7. PubMed ID: 26254990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
    Li LC; Li DL; Xu L; Mo XT; Cui WH; Zhao P; Zhou WC; Gao J; Li J
    J Pharmacol Exp Ther; 2015 Sep; 354(3):302-9. PubMed ID: 26126535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
    J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total polysaccharide of Yupingfeng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-β1-mediated type I collagen abnormal deposition in rats.
    Xu L; Li LC; Zhao P; Qi LW; Li P; Gao J; Fei GH
    J Pharm Pharmacol; 2014 Dec; 66(12):1786-95. PubMed ID: 25209833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Effect of Atazanavir Sulphate Against Pulmonary Fibrosis In Vivo and In Vitro.
    Song S; Ji Y; Zhang G; Zhang X; Li B; Li D; Jiang W
    Basic Clin Pharmacol Toxicol; 2018 Feb; 122(2):199-207. PubMed ID: 28816009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total glycosides of Yupingfeng protects against bleomycin-induced pulmonary fibrosis in rats associated with reduced high mobility group box 1 activation and epithelial-mesenchymal transition.
    Cui W; Li L; Li D; Mo X; Zhou W; Zhang Z; Xu L; Zhao P; Qi L; Li P; Gao J
    Inflamm Res; 2015 Dec; 64(12):953-61. PubMed ID: 26411348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
    Gao L; Jiang D; Geng J; Dong R; Dai H
    Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
    Qian W; Cai X; Qian Q; Zhang W; Wang D
    J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel formononetin-7-sal ester ameliorates pulmonary fibrosis via MEF2c signaling pathway.
    Zhao X; Qu G; Song C; Li R; Liu W; Lv C; Song X; Zhang J; Li M
    Toxicol Appl Pharmacol; 2018 Oct; 356():15-24. PubMed ID: 29990528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total extract of Yupingfeng attenuates bleomycin-induced pulmonary fibrosis in rats.
    Li L; Li D; Xu L; Zhao P; Deng Z; Mo X; Li P; Qi L; Li J; Gao J
    Phytomedicine; 2015 Jan; 22(1):111-9. PubMed ID: 25636879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
    Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
    Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
    Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
    Divya T; Velavan B; Sudhandiran G
    Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
    Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulindac has strong antifibrotic effects by suppressing STAT3-related miR-21.
    Zhou X; Li YJ; Gao SY; Wang XZ; Wang PY; Yan YF; Xie SY; Lv CJ
    J Cell Mol Med; 2015 May; 19(5):1103-13. PubMed ID: 25704671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.